Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | APAF1 | O14727 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18900795 | 1.00 | CBLB (0.36) | CBLBMAPK1ATMLMNAKDM4E | |
| SCHEMBL18806993 | 0.68 | MAPK1 (0.49) | CBLBMAPK1ATMLMNAKDM4E | |
| SCHEMBL18806998 | 0.68 | MAPK1 (0.36) | MAPK1ATMLMNAKDM4ECSNK2A1 | |
| SCHEMBL31030362 | 0.68 | MAPK1 (0.49) | CBLBMAPK1ATMLMNAKDM4E | |
| SCHEMBL14578729 | 0.68 | LMNA (0.64) | LMNAKDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL24884396 | 0.68 | LMNA (0.64) | LMNAKDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL12126327 | 0.67 | — | — | |
| SCHEMBL23989422 | 0.67 | — | — | |
| SCHEMBL2101508 | 0.67 | LMNA (0.32) | MAPK1ATMLMNAKDM4ECSNK2A1 | |
| SCHEMBL2099315 | 0.67 | LMNA (0.32) | MAPK1ATMLMNAKDM4ECSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170120163-A1 | SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES | PENTRACOR GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| EP-2957563-A1 | Separation material comprising phosphoryl choline derivatives | Pentracor GmbH (DE) | 2015-12-23 | — | — | EP | disclosed |
| WO-2015193504-A1 | SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES | PENTRACOR GMBH (DE) | 2015-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170120163-A1 | SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES | CHKA, PHOSPHO1, C3AR1 | CBLB 2846/4885MAPK1 1343/4885ATM 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.